Feedback / Questions
Xifaxan (rifaximin) - Alfa Wassermann, Bausch Health
SIMPACT: SIMBA in Irritable Bowel Syndrome (IBS)
(clinicaltrials.gov)
-
Oct 21, 2026 -
P1 | N=180 | Not yet recruiting | Sponsor: University of Calgary
New P1 trial
•
Gastrointestinal Disorder
http://clinicaltrials.gov/ct2/show/NCT07882953
Oct 21, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next